NDC 64406-008 – Tysabri
Natalizumab 300 mg/15mL · Injection · Intravenous
Product NDC64406-008
Product details
- Brand name
- Tysabri
- Generic name
- Natalizumab
- Labeler
- Biogen Inc.
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- BLA · BLA125104
- Marketed since
- November 23, 2004
- Listing expires
- December 31, 2026
- Pharmacologic class
- Integrin Receptor Antagonist
Active ingredients
- Natalizumab 300 mg/15mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 64406-008-01 | 1 VIAL, SINGLE-USE in 1 CARTON (64406-008-01) / 15 mL in 1 VIAL, SINGLE-USE | Nov 23, 2004 |